Substrate Utilization and Hormonal Status in Women
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Mar 29, 2010
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
24 healthy young women (12 with OC and 12 without any contraception) will complete a maximal test on an ergometer cycle to obtain their maximal oxygen consumption (VO2max).Their body composition will be assessed by DXA. They will be asked to complete 3 experimental sessions.
During a first session the volunteers will remain inactive, and only a breakfast will be offered. During the second session, a breakfast will be offered and they will have to complete a sub-maximal exercise set at 60% of their VO2max 3 hours after breakfast. And the third session will consist in the realisation of exer...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Adults between 19 to 30 years old
- • Body mass index between 20 and 25 kg.m-²
- • Oral contraception (half of the sample) : mini-dosed, and mono-phasic, ethinyl estradiol ≤ 30 µg
- • Without contraception (half of the sample)
- • Affiliated to National Health Insurance
- • Subject giving her written informed consent
- • Subject considered as normal after clinical examination and medical questionnaire.
- Exclusion Criteria:
- • Chronic pathologies : cardiovascular diseases, cancer, chronic inflammation diseases, renal, intestinal impairments
- • Refusal to be registered on the National Volunteers Data file
- • Being in exclusion on the National Volunteers Data file
- • Practising intensive physical exercise
- • Heavy consumer of alcohol or/and tobacco
- • Previous medical and/or surgery judged by the investigator as incompatible with this study
- • Pregnancy
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Patients applied
Trial Officials
Martine DUCLOS, Pr
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials